A new study from Karolinska Institutet, published in Cell Reports Medicine, shows that follicular lymphoma (FL), a common ...

The collaboration will fund early-stage clinical development of SB-4826, CIT’s first-in-class SUMO E1 inhibitor, for patients ...

Results from the Phase III EPCORE FL-1 trial (NCT05409066) showed that patients treated with Epkinly (epcoritamab) in ...

Genmab has announced that its phase 3 EPCORE FL-1 trial met both primary endpoints in patients with relapsed or refractory ...

A man from Swindon will be taking part in a 38-mile cycle after successfully undergoing treatment for follicular lymphoma.

A new study from Karolinska Institutet, published in Cell Reports Medicine, shows that follicular lymphoma (FL), a common ...

Follicular lymphoma survivor Troy Anderson credited acupuncture and nutrition guidance with easing treatment side effects and ...

Bristol Myers Squibb (BMS) has announced that its CD19-directed CAR T cell therapy Breyanzi (lisocabtagene maraleucel) has ...

Bristol Myers' Breyanzi sales surged 125% in Q2 to $344M, fueled by new approvals, strong demand and expanded market reach.

A local Omaha woman was the first to ever receive CAR T-cell therapy as an outpatient. Doctors said it was a success, and she ...

AstraZeneca's oncology sales jump 18% in second-quarter 2025, fueled by key drugs and new launches like Truqap and Datroway.